Literature DB >> 1317328

Ferritin as a source of iron for oxidative damage.

D W Reif1.   

Abstract

The generation of deleterious activated oxygen species capable of damaging DNA, lipids, and proteins requires a catalyst such as iron. Once released, ferritin iron is capable of catalyzing these reactions. Thus, agents that promote iron release may lead to increased oxidative damage. The superoxide anion formed enzymatically, radiolytically, via metal-catalyzed oxidations, or by redox cycling xenobiotics reductively mobilizes ferritin iron and promotes oxidative damage. In addition, a growing list of compounds capable of undergoing single electron oxidation/reduction reactions exemplified by paraquat, adriamycin, and alloxan have been reported to release iron from ferritin. Because the rapid removal of iron from ferritin requires reduction of the iron core, it is not surprising that the reduction potential of a compound is a primary factor that determines whether a compound will mobilize ferritin iron. The reduction potential does not, however, predict the rate of iron release. Therefore, ferritin-dependent oxidative damage may be involved in the pathogenesis of diseases where increased superoxide formation occurs and the toxicity of chemicals that increase superoxide production or have an adequate reduction potential to mobilize ferritin iron.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317328     DOI: 10.1016/0891-5849(92)90091-t

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  63 in total

Review 1.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

2.  Dietary iron to total energy intake ratio and type 2 diabetes incidence in a longitudinal 12-year analysis of the Korean Genome and Epidemiology Cohort Study.

Authors:  Dong-Hyuk Jung; Kyeng Won Hong; Byoungjin Park; Yong-Jae Lee
Journal:  Eur J Nutr       Date:  2021-06-03       Impact factor: 5.614

3.  Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury.

Authors:  Pavlína Hašková; Hana Jansová; Jan Bureš; Miloslav Macháček; Anna Jirkovská; Katherine J Franz; Petra Kovaříková; Tomáš Šimůnek
Journal:  Toxicology       Date:  2016-10-12       Impact factor: 4.221

4.  Paraquat-induced free radical reaction in mouse brain microsomes.

Authors:  W Yang; A Y Sun
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

5.  Ascorbic-acid-mediated iron release from cellular ferritin and its relation to the formation of DNA strand breaks in neuroblastoma cells.

Authors:  S L Baader; G Bruchelt; T C Carmine; H N Lode; A G Rieth; D Niethammer
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  Secondary alcohol metabolites mediate iron delocalization in cytosolic fractions of myocardial biopsies exposed to anticancer anthracyclines. Novel linkage between anthracycline metabolism and iron-induced cardiotoxicity.

Authors:  G Minotti; A F Cavaliere; A Mordente; M Rossi; R Schiavello; R Zamparelli; G Possati
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

7.  Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure.

Authors:  Jianling Wang; Huaxian Ma; Paul J Boor; V M Sadagopa Ramanujam; G A S Ansari; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2009-12-04       Impact factor: 7.376

8.  Iron chelation protects the retinal pigment epithelial cell line ARPE-19 against cell death triggered by diverse stimuli.

Authors:  Nina Lukinova; Jared Iacovelli; Tzvete Dentchev; Natalie Wolkow; Allan Hunter; Defne Amado; Gui-Shuang Ying; Janet R Sparrow; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

9.  Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.

Authors:  Hana Jansová; Miloslav Macháček; Qin Wang; Pavlína Hašková; Anna Jirkovská; Eliška Potůčková; Filip Kielar; Katherine J Franz; Tomáš Simůnek
Journal:  Free Radic Biol Med       Date:  2014-06-30       Impact factor: 7.376

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.